Articles: nausea.
-
The prevalence of symptoms in thyrotoxicosis at the time of diagnosis has received little attention in studies of this condition. Vomiting, nausea, and abdominal pain have not been included as common presenting symptoms for thyrotoxicosis in standard textbooks of medicine and endocrinology. Some reports in the medical literature, however, indicate that these abdominal symptoms may be important manifestations of this condition. ⋯ Of 25 thyrotoxic patients who had thyrotoxicosis diagnosed during or immediately prior to admission, 44% reported vomiting, 28% reported nausea, and 20% complained of abdominal pain. One or more of these abdominal symptoms were included as a chief complaint in 36% of cases reviewed. Further study of the clinical presentation of thyrotoxicosis in the outpatient setting is needed to improve the timeliness and cost effectiveness of the clinical diagnosis of this condition.
-
Southern medical journal · Oct 1989
Randomized Controlled Trial Comparative Study Clinical TrialMetoclopramide versus droperidol for prevention of nausea and vomiting during epidural anesthesia for cesarean section.
In a randomized, double-blind study, we compared the efficacy of metoclopramide hydrochloride with that of low-dose droperidol for prevention of nausea and vomiting during and after elective cesarean section with epidural anesthesia. Immediately after the umbilical cord was clamped, each patient received fentanyl (50 micrograms) and the study drug intravenously over 30 to 60 seconds. In one study group, 40 women received metoclopramide (15 mg); in the other group, 41 women received droperidol (0.5 mg). ⋯ During the first four postoperative hours, five women (12%) in each group complained of nausea. Three women (7%) in each group had postoperative vomiting. We conclude that metoclopramide (15 mg) and droperidol (0.5 mg) were similarly effective.
-
Oncology nursing forum · Jul 1989
ReviewManaging chemotherapy-related nausea and vomiting: the state of the art.
The consequences of inadequately controlled chemotherapy-related nausea and vomiting range from minor discomfort to dose-limiting toxicity. Physical complications may occur secondary to protracted nausea and emesis. ⋯ An understanding of the patterns, mechanisms, and risk of chemotherapy-related nausea and vomiting is crucial to providing optimal patient care. Concepts of drug therapy are emphasized as the cornerstone of antiemetic management.
-
Nausea and vomiting are frequent disturbances in the first trimester of pregnancy, sometimes they may take the form of hyperemesis, even life-threatening. The authors survey the concepts of the aetiology and pathogenesis of the condition: hormonal, metabolic, psychological. Principles of management using simple methods reducing the ++ill being of the pregnant patients are presented, together with pharmacological management of hyperemesis. The suggested therapeutic methods seem to be relatively safe for the fetus and practically eliminate the necessity of pregnancy interruption for medical indications.
-
Anesthesia and analgesia · Jun 1989
Clinical Trial Controlled Clinical TrialDose-response study of droperidol and metoclopramide as antiemetics for outpatient anesthesia.